Safety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study

Presented at last week’s ASCO Gastrointestinal Cancers Symposium, noteworthy studies incuded new approaches to treating and managing gastric cancer including the safety and efficacy of durvalumab.